[Drug therapy of hypercholesterinemias (author's transl)].
Every permanent substantiated primary hypercholesterolemia which does not respond adequately to diet must be treated with drugs. For monotherapy first of all fenofibrate, bezafibrate and nicotinic acid derivatives are suitable for the treatment of adult patients. For supportive therapy colestyramine and colestipol come into consideration as well as beta-sitosterol. D-thyroxine and etiroxate should be reserved for refractory cases. Drug therapy is only given for secondary hypercholesterolemias in justifiable exceptions.
D000328:Adult; D001629:Bezafibrate; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002995:Clofibric Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D003084:Colestipol / Q000627:therapeutic use; D003918:Dextrothyroxine / Q000627:therapeutic use; D011345:Fenofibrate / Q000627:therapeutic use; D006801:Humans; D006937:Hypercholesterolemia / Q000178:diet therapy / Q000188:drug therapy*; D009355:Neomycin / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use*; D012855:Sitosterols / Q000627:therapeutic use
D009539:Nicotinic Acids; D012855:Sitosterols; D002792:Cholestyramine Resin; D003918:Dextrothyroxine; D002995:Clofibric Acid; D009355:Neomycin; D003084:Colestipol; D011345:Fenofibrate; D001629:Bezafibrate
Medikamentöse Therapie der Hypercholesterinmien.